These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1175 related items for PubMed ID: 31325708

  • 1. miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer.
    Vo DT, Karanam NK, Ding L, Saha D, Yordy JS, Giri U, Heymach JV, Story MD.
    Neoplasia; 2019 Sep; 21(9):849-862. PubMed ID: 31325708
    [Abstract] [Full Text] [Related]

  • 2. MiR-125 family improves the radiosensitivity of head and neck squamous cell carcinoma.
    Wang QW, Sun YN, Tan LJ, Zhao JN, Zhou XJ, Yu TJ, Liu JT.
    Mol Biol Rep; 2023 Jun; 50(6):5307-5317. PubMed ID: 37155009
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-125a-5p plays a role as a tumor suppressor in lung carcinoma cells by directly targeting STAT3.
    Zhong L, Sun S, Shi J, Cao F, Han X, Chen Z.
    Tumour Biol; 2017 Jun; 39(6):1010428317697579. PubMed ID: 28631574
    [Abstract] [Full Text] [Related]

  • 4. Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs.
    Koshizuka K, Nohata N, Hanazawa T, Kikkawa N, Arai T, Okato A, Fukumoto I, Katada K, Okamoto Y, Seki N.
    Oncotarget; 2017 May 02; 8(18):30288-30304. PubMed ID: 28415821
    [Abstract] [Full Text] [Related]

  • 5. miR-96-5p targets PTEN expression affecting radio-chemosensitivity of HNSCC cells.
    Vahabi M, Pulito C, Sacconi A, Donzelli S, D'Andrea M, Manciocco V, Pellini R, Paci P, Sanguineti G, Strigari L, Spriano G, Muti P, Pandolfi PP, Strano S, Safarian S, Ganci F, Blandino G.
    J Exp Clin Cancer Res; 2019 Mar 29; 38(1):141. PubMed ID: 30925916
    [Abstract] [Full Text] [Related]

  • 6. Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck Cancer.
    Saleh AD, Cheng H, Martin SE, Si H, Ormanoglu P, Carlson S, Clavijo PE, Yang X, Das R, Cornelius S, Couper J, Chepeha D, Danilova L, Harris TM, Prystowsky MB, Childs GJ, Smith RV, Robertson AG, Jones SJM, Cherniack AD, Kim SS, Rait A, Pirollo KF, Chang EH, Chen Z, Van Waes C.
    Clin Cancer Res; 2019 May 01; 25(9):2860-2873. PubMed ID: 30723145
    [Abstract] [Full Text] [Related]

  • 7. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
    Koshizuka K, Hanazawa T, Kikkawa N, Katada K, Okato A, Arai T, Idichi T, Osako Y, Okamoto Y, Seki N.
    Auris Nasus Larynx; 2018 Aug 01; 45(4):854-865. PubMed ID: 29233721
    [Abstract] [Full Text] [Related]

  • 8. Identification of Tumor Suppressive Genes Regulated by miR-31-5p and miR-31-3p in Head and Neck Squamous Cell Carcinoma.
    Oshima S, Asai S, Seki N, Minemura C, Kinoshita T, Goto Y, Kikkawa N, Moriya S, Kasamatsu A, Hanazawa T, Uzawa K.
    Int J Mol Sci; 2021 Jun 08; 22(12):. PubMed ID: 34201353
    [Abstract] [Full Text] [Related]

  • 9. Regulation of ITGA3 by the anti-tumor miR-199 family inhibits cancer cell migration and invasion in head and neck cancer.
    Koshizuka K, Hanazawa T, Kikkawa N, Arai T, Okato A, Kurozumi A, Kato M, Katada K, Okamoto Y, Seki N.
    Cancer Sci; 2017 Aug 08; 108(8):1681-1692. PubMed ID: 28612520
    [Abstract] [Full Text] [Related]

  • 10. MiR-125a-5p inhibits cell proliferation, cell cycle progression, and migration while promoting apoptosis in head and neck cancers by targeting ERBB3.
    Xu M, Zhan J, Xie J, Zhu L, Chen L, Luo X, Sheng X, Liu T, Zhang S, Lu Z.
    Auris Nasus Larynx; 2021 Jun 08; 48(3):477-486. PubMed ID: 33077307
    [Abstract] [Full Text] [Related]

  • 11. Impact of Oncogenic Targets by Tumor-Suppressive miR-139-5p and miR-139-3p Regulation in Head and Neck Squamous Cell Carcinoma.
    Koma A, Asai S, Minemura C, Oshima S, Kinoshita T, Kikkawa N, Koshizuka K, Moriya S, Kasamatsu A, Hanazawa T, Uzawa K, Seki N.
    Int J Mol Sci; 2021 Sep 14; 22(18):. PubMed ID: 34576110
    [Abstract] [Full Text] [Related]

  • 12. miR-17-5p drives G2/M-phase accumulation by directly targeting CCNG2 and is related to recurrence of head and neck squamous cell carcinoma.
    Huang Q, Shen YJ, Hsueh CY, Guo Y, Zhang YF, Li JY, Zhou L.
    BMC Cancer; 2021 Oct 02; 21(1):1074. PubMed ID: 34598688
    [Abstract] [Full Text] [Related]

  • 13. Dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p) coordinately targeted MTDH in lung squamous cell carcinoma.
    Mataki H, Seki N, Mizuno K, Nohata N, Kamikawaji K, Kumamoto T, Koshizuka K, Goto Y, Inoue H.
    Oncotarget; 2016 Nov 01; 7(44):72084-72098. PubMed ID: 27765924
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab.
    Nishida N, Mimori K, Fabbri M, Yokobori T, Sudo T, Tanaka F, Shibata K, Ishii H, Doki Y, Mori M.
    Clin Cancer Res; 2011 May 01; 17(9):2725-33. PubMed ID: 21220473
    [Abstract] [Full Text] [Related]

  • 15. Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.
    Kimura S, Naganuma S, Susuki D, Hirono Y, Yamaguchi A, Fujieda S, Sano K, Itoh H.
    Oncol Rep; 2010 Jun 01; 23(6):1625-33. PubMed ID: 20428818
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis.
    Baba O, Hasegawa S, Nagai H, Uchida F, Yamatoji M, Kanno NI, Yamagata K, Sakai S, Yanagawa T, Bukawa H.
    J Oral Pathol Med; 2016 Apr 01; 45(4):248-55. PubMed ID: 26307116
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA-125a-5p modulates radioresistance in LTEP-a2 non-small cell lung cancer cells by targeting SIRT7.
    Sun C, Zeng X, Guo H, Wang T, Wei L, Zhang Y, Zhao J, Ma X, Zhang N.
    Cancer Biomark; 2020 Apr 01; 27(1):39-49. PubMed ID: 31683458
    [Abstract] [Full Text] [Related]

  • 18. Down-Regulated miR-125a-5p Promotes the Reprogramming of Glucose Metabolism and Cell Malignancy by Increasing Levels of CD147 in Thyroid Cancer.
    Huang P, Mao LF, Zhang ZP, Lv WW, Feng XP, Liao HJ, Dong C, Kaluba B, Tang XF, Chang S.
    Thyroid; 2018 May 01; 28(5):613-623. PubMed ID: 29634399
    [Abstract] [Full Text] [Related]

  • 19. miR-21 increases the programmed cell death 4 gene-regulated cell proliferation in head and neck squamous carcinoma cell lines.
    Sun Z, Li S, Kaufmann AM, Albers AE.
    Oncol Rep; 2014 Nov 01; 32(5):2283-9. PubMed ID: 25175929
    [Abstract] [Full Text] [Related]

  • 20. Tumor suppressive microRNA-133a regulates novel targets: moesin contributes to cancer cell proliferation and invasion in head and neck squamous cell carcinoma.
    Kinoshita T, Nohata N, Fuse M, Hanazawa T, Kikkawa N, Fujimura L, Watanabe-Takano H, Yamada Y, Yoshino H, Enokida H, Nakagawa M, Okamoto Y, Seki N.
    Biochem Biophys Res Commun; 2012 Feb 10; 418(2):378-83. PubMed ID: 22266319
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.